SCHOTT to Produce More Pharmaceutical Glass

In response to growing global demand, the SCHOTT Group is expanding its production capacity for pharmaceutical glass. The company plans to put a new melting tank for its Type I glass named FIOLAX® clear into operation at its site in Mitterteich, Germany. From 2015 to 2016, SCHOTT will be investing a sum in the mid-double-digit millions in the expansion. This move will increase the company’s production capacity for glass tubing to more than 140,000 tons.

 

FIOLAX® glass tubing is used to manufacture high-quality vials, syringes, ampoules and cartridges. The pharmaceutical industry then fills these with injectable drugs. The needs of the pharmaceutical companies for such high-quality packaging are rising steadily because of an ever-increasing regulatory pressure and more stringent standards for patient safety. FIOLAX® is designed to meet these exact requirements. Thanks to its special properties and its chemical resistance the drugs are kept stored in the best possible way. Since it was first developed more than 100 years ago, FIOLAX® has grown to become the de-facto standard for glass packaging in the pharmaceutical industry

 

Construction work on the new tank has already begun and will be completed in spring 2016. Moreover, a new palletizing line will complement the extension.

 

“Given the growing size of India’s pharma market and the significance of quality packaging for life saving drugs, we need to keep up with the extraordinary demand of the market. Thus, we welcome the introduction of the new melting tank at our Germany site to further ensure timely and efficient supply of the most important base material- world market leading SCHOTT FIOLAX® tubes,” said Vice President- Sales and Marketing, SCHOTT Glass India Pvt. Ltd., Mr. Sundeep Prabhu.
Corporate Comm India (CCI Newswire)